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Abstract.  We have devised a  genetic selection for mu- 
tant yeast cells that fail to translocate secretory protein 
precursors into the lumen of the endoplasmic reticu- 
lum (ER).  Mutant cells are selected by a procedure 
that requires a  signal peptide-containing cytoplasmic 
enzyme chimera to remain in contact with the cytosol. 
This approach has uncovered a  new secretory mutant, 
sec61,  that is thermosensitive for growth and that ac- 
cumulates multiple secretory and vacuolar precursor 
proteins that have not acquired any detectable post- 
translational modifications associated with transloca- 
tion into the ER.  Preproteins that accumulate at the 
sec61  block sediment with the particulate fraction, but 
are exposed to the cytosol as judged by sensitivity to 
proteinase K. Thus, the sec61  mutation defines a  gene 
that is required for an early cytoplasmic or ER mem- 
brane-associated step in protein translocation. 
T 
hE first step in the biogenesis of proteins destined for 
the secretory pathway is their insertion into the mem- 
brane of the endoplasmic reticulum (ER).I This pro- 
cess  has  been  studied  intensively  in  mammalian  cells 
through the use of an in vitro assay that faithfully  reproduces 
cotranslational translocation of secretory proteins into the lu- 
men of the ER (2).  Dissection of the components required 
for this activity has revealed the existence of  both soluble and 
membrane-bound factors that participate in protein translo- 
cation. The signal recognition particle is a soluble ribonu- 
cleoprotein particle consisting of six polypeptides (54)  and 
one molecule of  7SL RNA (55). The signal recognition parti- 
cle binds to the signal sequence of a nascent preprotein (28, 
56), thereby forming a complex that interacts with an integral 
membrane protein of the ER known as docking protein or 
signal recognition particle receptor (13, 33).  This targeting 
event is followed by cotranslational translocation of the pre- 
protein into the ER lumen. Either during or shortly after the 
translocation event, the signal sequence is cleaved by the en- 
zyme signal peptidase  (10) and core oligosaccharides are 
transferred to specific asparagine residues (44) of  the translo- 
cated polypeptide.  The mechanism of protein permeation 
across the hydrophobic core of the ER membrane is not un- 
derstood. Experiments with intermediates artificially blocked 
at various stages of membrane penetration suggest that this 
process is mediated by proteins, though they have yet to be 
identified by the existing assays (14). 
Recently, several groups have reconstituted protein trans- 
location into the yeast ER in vitro (15, 42, 57). A yeast trans- 
lation extract programmed with prepro-ct-factor mRNA di- 
1.  Abbreviations used in  this paper:  CPY, carboxypeptidase  Y;  ER, en- 
doplasmic  retieulum;  proCPY,  procarboxypeptidase  Y;  Ts,  temperature 
sensitive; YPD,  1% yeast extract, 2% peptone, 2% dextrose. 
rects the synthesis of an intact precursor which can insert 
co- or posttranslationaUy into yeast microsomes and become 
core-glycosylated. The existence of a posttranslational reac- 
tion has allowed these investigators to demonstrate that pro- 
tein translocation into the yeast ER is energy dependent (15, 
43, 57). In addition, fractionation experiments suggest that 
the import reaction requires cytosolic components (58).  The 
reconstitution of yeast protein translocation in vitro presents 
an opportunity to combine a biochemical analysis of protein 
translocation with a genetic approach aimed at identifying 
genes  whose products participate  in the reconstituted re- 
action. 
Among a large collection of temperature-sensitive, secre- 
tion-defective mutants of Saccharomyces cerevisiae isolated 
in this laboratory (12, 36,  37),  members of only two com- 
plementation groups (sec53 and sec59) affect early events in 
protein  secretion,  though neither mutation blocks protein 
translocation into the ER (10a). In an attempt to identify 
genes required for the translocation event, we have devel- 
oped a direct selection for temperature-sensitive (Ts), import 
mutants of Saccharomyces cerevisiae. 
The protocol described in this report is similar to that used 
by Oliver and Beckwith (39)  to isolate mutants of Esche- 
richia coli defective in the export of  periplasmic and cell wall 
proteins from the cytoplasm. Strains expressing abortively 
translocated fusions of the periplasmic maltose-binding pro- 
tein (MBP) to ~-galactosidase produced much less 13-galacto- 
sidase activity than strains harboring similar fusions with 
mutations in the maltose-binding protein signal sequence. By 
selecting for mutants that expressed high levels of ~-galacto- 
sidase activity from the wild-type fusion protein (presum- 
ably owing to retention of  the fusion protein in the cytoplasm), 
Oliver and Beckwith (39) were able to isolate mutations in 
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tion of multiple secretory precursors. 
We have modified this strategy to select positively for mu- 
tants of Saccharomyces cerevisiae that are defective in pro- 
tein translocation.  In this report, we describe the isolation 
and phenotypic characterization of mutants that define two 
complementation groups (see61 and see62).  Mutations  in 
both genes cause temperature-sensitive growth and accumu- 
lation of a-factor precursor. Detailed analysis of sec61 strains 
has revealed that this mutation results in the accumulation of 
cytoplasmically exposed and unmodified precursors of mul- 
tiple secretory and vacuolar proteins. 
Materials and Methods 
Strains, Growth Conditions, and Materials 
The bacterial and yeast strains used in this study are listed in Table I. All 
plasmids were propagated in HB101, except those sensitive to restriction by 
BclI, which were propagated in NK 5772.  Yeast strains were constructed 
by standard genetic techniques (48).  Original mutant isolates were back- 
crossed at least three consecutive times to RDB 103 to test for cosegregation 
of the Ts growth and a-factor accumulation phenotypes. All experiments 
were performed with these backcrossed derivatives. Haploid sec61 strains 
were recovered from the original sec61 diploid isolates by mating the diploid 
mutant  to  diploid  $395D-1,  sporulating  this  tetraploid  strain,  and  then 
sporulating a Ts MATa/Mata  diploid spore clone derived from the tetra- 
ploid. Haploid MATa mutant strains were then backcrossed with RDB 103. 
YPD liquid broth contained 1% Bacto-Yeast extract, 2 % Bacto-Peptone 
(Difco Laboratories, Detroit, MI), and 2-5% glucose. Wickerham's mini- 
mal medium (59)  was used with 2-5 % glucose.  Solid media were sup- 
plemented with 2% Bacto-Agar. For pulse labeling of cells with [35S]SO~4-, 
sulfate salts were replaced by chloride salts, and ammonium sulfate was sup- 
plemented at 200 p.M for overnight growth and at 0-10 ~tM during radio- 
labeling. Liquid cultures were grown in flasks with vigorous agitation, and 
experiments were initiated with cells in logarithmic phase. The optical den- 
sity at 600 nm (OD6~o) of dilute cell suspensions was measured in  1-cm 
quartz cuvettes using a Zeiss PMQII spectrophotometer (Carl Zeiss, Inc., 
Thoruwood, NY);  10D~  of cells corresponds to 0.15 nag of dry weight. 
The following reagents were obtained as indicated: histidinol, tunicamy- 
cin, ethyl methanesulfonate, concanavalin  A(Con A)-Sepharose 4B, a-meth- 
ylmannoside, NADPH, cytochrome c, proteinase K, protein A, bovine se- 
rum albumin, and phenylmethylsulfonyl fluoride (PMSF) were obtained 
from Sigma Chemical Co., St. Louis, MO; restriction endonucleases, DNA 
modification enzymes, and nuclease-treated wheat germ in vitro translation 
components were from Bethesda Research  Laboratories,  Gaithersburg, 
MD; T4 DNA ligase and glyceraldehyde-3-phosphate  (diethylacetyl form) 
were from Boehringer Mannheim Biochemicals, Indianapolis, IN; Amplify, 
[35S]methionine  (1,200  Ci/mmol), and ~25I-NaI (highest specific activity) 
were from Amersham Corp., Arlington Heights, IL; SDS-polyacrylamide 
gel electrophoresis reagents (electrophoresis grade)  were from Bio-Rad 
Laboratories, Richmond, CA; nitrocellulose was from Schleicher & Schuell, 
Inc., Keene, NH; protein A-Sepharose was from Pharmacia Fine Chemi- 
cals, Piscataway,  NJ; carrier-free [35S]Na2SOa was from ICN Radiochemi- 
cals, Irvine, CA; IgG Sorb was from The Enzyme Center, Boston, MA; and 
nonfat dry milk was from Safeway, North Berkeley,  CA. Lyticase (fraction 
If, 30,000-90,000  U/ml) was prepared as described by Scott and Schekman 
(46).  Invertase (45)  and carboxypeptidase Y  (50)  antisera were prepared 
as described previously. Anti-a-factor sera was generously provided by 
J. Rothblatt, European Molecular Biology Laboratory, Heidelberg, Federal 
Republic of Germany (42).  Rabbit reticulocyte lysate was prepared as de- 
scribed (1). 
Construction of  HIS4 Gene Fusions 
A  SUC2-HIS4  gene  fusion was  constructed in the yeast  shuttle vector 
YCp50, which is a low copy number plasmid that contains URA3 as a selec- 
table marker and CEN4 ARS1 for mitotic stabilization and replication com- 
petence, respectively (51). In the first step, the 1.6-kb Eco RI-Bam HI frag- 
ment from the 5' portion of the SUC2 gene (from pRB58 [5]) was inserted 
between the  unique  Eco  RI  and  Bam  HI  sites  in  YCp50  to  generate 
YCp50  Es. Next, the 1.6-kb Xho II fragment of pYAH-I2 (40), which con- 
tains the 5' portion of HIS4,  was inserted into the Bam HI site of YCp50 ~B 
to generate YCp501.  The remainder of the HIS4 gene was introduced by 
replacing the 1,350-bp Cla I-Sph I fragment of YCp501 with the correspond- 
ing 2.7-kb fragment from pYAH-I2 resulting in plasmid YCp502, which con- 
tains almost the entire HIS4 gene (except for the first 33 codons of HIS4A) 
fused out of frame to the 5' half of the SUC2 gene. An in-frame SUC2-HIS4 
fusion was created by inserting the 250-bp Barn HI-Bcl I fragment of SUC2 
into the unique Bam HI site of YCp502, yielding YCp503.  Unfortunately, 
this fusion plasmid failed to complement his4C mutations, even though a 
hybrid protein of the proper size was synthesized constitutively. 
We reasoned that an increase in the copy number of the SUC2-HIS4 fu- 
sion might allow complementation of his4C strains. Thus, the fusion gene 
was introduced into a multicopy 2 tim-based vector. The junction sequences 
and HIS4  coding portion of the SUC2-HIS4  fusion were transferred to 
Table I.  Bacterial  and Yeast Strains 
Strain  Genotype  Source or reference 
Saccharomyces cerevisiae 
RDB  103 
RDM  15-5B 
RDM  15-9B 
RDM  15-10D 
RDM  15-3A 
FC2-12B 
DYFC2-12B 
$395D-1 
PBY404C 
165/7 
E331 
$942-1Ca 
Escherichia  coli 
NK5772 
HB101 
leu2-3,-112  ade2 MATa 
leu2-3,-112  ade2 ura3-52  pep4-3  see61-2  MATa 
ade2  pep4-3  Matft 
leu2-3,-112  ade2  secl8-1  MATer 
1eu2-3,-112  his4 pep4-3  secl8-1  see61-2  MATa 
leu2-3,-112  ura3-52  trpl-1  his4-401  HOLI-1  MATer 
leu2-3,-112/leu2-3,-112  ura3-52/ura3-52  trpl-1/trpl-1 
his4-401/his4-401  HOLI-1/HOLI-1  MATa/MATct 
hisl/hisl  leul/leul  trp2/trp2  MATa/MATa 
suc2-A9 MATa 
his4-25  (his4A-) MATa 
his4-331  (his4B-) MATa 
his4-864  (his4C-) MATa 
dcm-6 dam-3  galK2 galT22  metB1  leuY1  tsx-78  thi-1 
tonA31  mtl- 1 
F- hsdS20  (rB-,  mB-)  recA13 ara-14 proA2  lacYl  galK2 
rpsL20 (Sm  r) xyl-5 mtl-1  supE44 
This study 
This study 
This study 
This study 
This study 
R.  Parker  (40) 
This study* 
YGSC* 
P.  B/Shni 
R.  Parker (40) 
R.  Parker  (40) 
R.  Parker  (40) 
J.  Kadonaga 
(30) 
* Spontaneously  derived from FC2-12B. 
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Sal I, to generate a 3.4-kb Bam HI-Sal I fragment. This fragment was in- 
serted in place of the 4.2-kb Bam HI-Sal I fragment (containing the 3' half 
of SUC2) of pRB58. The resulting plasmid, pSHE1, produced more fusion 
protein and complemented mutations in his4A, 4B, and 4C. 
Expression of the cytoplasmic invertase-HlS4 fusion protein was elimi- 
nated by replacing the extreme 5' portion of the SUC2 coding region with 
the promoter elements and coding sequences for the prepro region of the 
yeast MFal gene. This replacement was accomplished by inserting the 1.9- 
kb Bgl II-Bam HI fragment of  pSEY210 (8) into the site vacated by complete 
digestion of pSHE1  with Bam HI, and partial digestion with Bcl I (the rele- 
vant Bcl I site is at the extreme 5' end of the SUC2 insert; the excised frag- 
ment is 2.7 kb). The product of this manipulation was designated pctSHFS. 
In contrast to the SUC2-HIS4 fusion, which contained amino acid residues 
1-289 of secretory invertase, p~tSHF8  encoded a  fusion protein in which 
the first 88 amino acids of the prepro region of a-factor were fused in frame 
to invertase starting at amino acid 5 of the signal peptide sequence. This 
resulted in the deletion of four amino acids from the NH2 terminus of the 
invertase portion of the MFal-SUC2-HIS4  fusion (see Emr et al., [8]). 
Plasmids were introduced into yeast strains either by the spheroplast (17) 
or lithium acetate  (19) procedure.  Agarose gel electrophoresis, plasmid 
purification, fragment isolation, transformation of bacteria, and other re- 
combinant DNA manipulations were performed by standard methods (30). 
All recombinant DNA modifying enzymes were used according to the sup- 
pliers' instructions. 
Mutant Isolation and Screening 
FC2-12B and DYFC2-12B cells containing paSHF8 were grown to station- 
ary phase in minimal medium supplemented with histidine, tryptophan, and 
lencine. 120D~o U of cells were harvested by centrifugation, washed with 
sterile 50  mM potassium phosphate buffer,  pH  7.0, and resuspended at 
20D600/ml  in potassium phosphate buffer.  Ethyl methanesulfonate was 
added to a final concentration of 3 %, and the cells were incubated with the 
mutagen for 60 rain (round II) or 75 min (round I) at 30°C (% killing  = 
50% in round I, 73%  in round II). The mutagen was quenched by adding 
an equal volume of sterile 12 % sodium thiosulfate, and cells were collected 
by centrifugation, washed two times consecutively with potassium phos- 
phate buffer and resuspended in 30 ml of minimal medium supplemented 
with leucine, tryptophan, and histidine. After a 20-h recovery period at 
24°C, the mutagenized cells were centrifuged, resuspended to 50D600/mi 
in potassium phosphate buffer and plated onto minimal medium supple- 
mented with leucine, tryptophan, and 3 mM histidinol (I-3  x  106 cells per 
plate). After incubation at 30°C for 5-10 d, mutant clones were picked and 
steaked onto YPD plates. After 2 d  at 30°C these patches were repliea- 
plated onto YPD plates and individual replicas were incubated at 30 and 
37°C. Clones that grew at 30°C but not at 37°C were picked and retested 
for Ts growth by streaking onto YPD plates at 37°C.  Confirmed histidin- 
ol  ÷, Ts mutants were cured of the fusion plasmid by streaking them three 
times consecutively on nonselective medium (YPD).  Uracil auxotrophs 
were  isolated,  rescreened for Ts  growth,  and  retransformed with  fresh 
paSHF8 to assess the linkage of the Ts and histidinol  + phenotypes to the 
original plasmid. 
Ura- derivatives of the original isolates were screened by immunoblot- 
ting for the accumulation of intracellular forms of prepro-¢t-factor. Briefly, 
mutant colonies were inoculated into 3 ml of YPD and grown at 30°C to 
an OD600 of 1.5-15. 40D600 U of cells were collected and diluted to a vol- 
ume of 3 ml with fresh YPD. These cultures were incubated for 2-3 h at 
37°C and then diluted with an equal volume of ice-cold 20 mM NaN3. The 
cells were collected by centrifugation, washed with ice cold 10 mM NAN3, 
and resuspended in 0.3 ml Laemmli sample buffer (29) supplemented with 
1 mM PMSE Glass beads (,'00.3 g of 0.3-0.5-mm diam) were added and 
the mixture was vortexed vigorously for 2 min, then immediately heated in 
boiling water for 5 min. Aliquots (24 I.tl) of these samples were applied to 
12.5 % SDS polyacrylamide gels and electrophoresis was performed as de- 
scribed by Laemmli (29). 
Electrophoretically separated proteins were transferred to nitrocellulose 
filters (4), and the filters were processed essentially as described by Kaiser 
and Botstein (23),  except that the blocking incubation was for 30 min at 
24°C, and anti-a-factor antiserum 0/500 dilution) was used to probe the 
filters. An unfractionated lysate, prepared from MATa cells (PBY404C), was 
included at a final concentration of 3-5 mg of  protein/ml during the antibody 
incubation to  block  antibody association with filter-bound proteins not 
related to a-factor. After decoration of bound antibodies with ~25I-labeled 
protein A, filters were exposed to X-ray film with an intensifying screen at 
-70°C. 
Radiolabeling and Immunoprecipitation 
Cells were grown overnight in minimal medium supplemented with 200 txM 
(NH4)2SO4 to an OD60o of 0.5-1.0.  An aliquot of cells was sedimented for 
2-3 min at room temperature in a clinical centrifuge, washed with distilled 
water, and resuspended to 1-20D600/ml in minimal medium supplemented 
with 0-10 ItM (NH4)2SO4. For radiolabeling of invertase, cells were first 
derepressed for invertase production by incubation in minimal medium 
(200 laM ammonium sulfate) plus 0.1% glucose for 30 rain at 30 or 37°C, 
then collected and resuspended in minimal medium containing 0-10 mM 
(NH4)2SO4 and 0.1% glucose. Radioactive sulfate (H235SO4) was added at 
a concentration of 200-300 IxCi/OD~o,  and incorporation was carried out 
for 20--40 rain at 30 or 37°C. Labeling was terminated by the addition of 
an equal volume of ice-cold 20 mM NAN3, and samples were chilled on 
ice for 5 min. Radioactive cells were sedimented in a clinical centrifuge, 
washed with ice-cold 10 mM NAN3, and resuspended at 5-20 OD600/ml in 
spheroplasting buffer, which contains 1.4 M sorbitol, 60 mM 13-mercapto- 
ethanol, 25  mM MOPS, pH 7.4,  10 mM NAN3, 5 mM MgC12. Lyticase 
was added (25 U/OD600) and cells were converted to spheroplasts during a 
45-min incubation at 30°C. Spheroplasts were sedimented for 20 s in a mi- 
crocentrifuge, re,  suspended to 5-10 OD600/mi in 1% SDS, heated to 100°C 
for 4 rain, and centrifuged for 10 rain in a microcentrifuge (Oscar Fisher 
Co., Inc., Newburgh, NY) to remove insoluble material. Aliquots of  the su- 
pernatant fractions were diluted to 1.0 ml in 200 mM NaC1,  12.5 mM so- 
dium phosphate, pH 7.4  (PBS),  1%  Triton X-100, 0.25%  SDS.  a-Factor 
(1 t~l/OD600 cell equivalent),  invertase (1.5  ~tl/OD~00 cell equivalent) or 
carboxypeptidase Y  (CPY)  (2  p.l/OD600 cell equivalent)  antiserum was 
added in saturating amounts, and immunoprecipitations were carded out for 
3-16  h at 4°C.  For a-factor and invertase immunoprecipitations, samples 
were supplemented with an unfractionated lysate of nonradioactive cells 
(2 mg protein/ml) from strain PBY404C  (suc2A,  MATa). After the anti- 
body incubation, protein A-Sepharose  was added in saturating amounts (1 Ixl 
beads/Ixl  antiserum) and the incubation was continued for 1-2 h at room 
temperature. Immune complexes were sedimented in a microcentrifuge, and 
washed sequentially with PBS, 1% Triton X-100, 0.1% SDS (two times), and 
50 mM NaCl, 10 mM Tris, pH Z4 (two times). Bound antigens were then 
dissociated by heating in Laemmii sample buffer, and samples were applied 
to 7.5%  (for invertase and CPY) or 12.5% (for prepro-a-factor) SDS poly- 
acrylamide gels. After SDS-PAGE, the gels were fixed and treated with Am- 
plify. Radioactive proteins were visualized by exposure to Kodak X-OMAT 
AR film (Eastman Kodak Co., Rochester, NY) at -70°C. Autoradiograms 
were quantified by scanning with a  Kratos model SD3000  spectrodensi- 
tometer coupled to a Kratos SDS300 density computer (Kratos Analytical 
Instruments, Ramsey, N J) and Hewlett-Packard 3380A integrator (Hewlett- 
Packard Co., Palo Alto, CA). 
Glycoprotein Precipitation with Con A-Sepharose 4B 
Cells were labeled with [a5s]so~4- and extracts were diluted l0 fold with 
concanavalin A reaction buffer (0.5 M NaC1, 20 mM Tris, pH Z4, 2% Tri- 
ton X-100) and split into two equal portions. One half was immunoprecipi- 
tated directly with antibodies against ct-factor or CPY, and the other was 
treated with Con A-Sepharose 4B beads (30 ~tl packed volume of beads for 
the amount of whole-cell extract derived from 10D600  of cells) for 3 h at 
room temperature. Con A-coated beads were then sedimented in a micro- 
centrifuge. The supernatant fraction (unbound) was removed, adjusted to 
0.2 % SDS, and heated in boiling water for 3 rain; the beads (bound fraction) 
were washed two times with con A reaction buffer and Con A-bound glyco- 
proteins were eluted by heating the beads in 200 I,  tl 1% SDS at 100°C. The 
eluate was clarified by centrifugation and diluted to 1.0 ml in Con A reaction 
buffer.  Unbound and bound fractions were then immunoprecipitated with 
a-factor or CPY antiserum as described in the preceding section. 
Subcellular Fractionation and Proteolysis of 
secl8 sec61 Extracts 
Fractionation of RDM 15-3A extracts was performed as described by Bern- 
stein et al. (1) except that prior to spheroplast formation the culture was in- 
cubated for 60 min at 30°C in YPD containing 5% glucose. Immunoblotting 
was performed as described above in  Mutant  Isolation  and  Screening. 
NADPH  cytochrome c  reductase  (25),  glyceraldehyde-3-phosphate de- 
hydrogenase (1), and total protein (31) were assayed as previously described. 
The latency of the NADPH cytochrome c reductase activity was determined 
by performing assays in the absence and presence of 0.1% Triton X-100. 
Determinations of the proteolytic sensitivity of accumulated prepro-tt- 
Deshaies  and Schekman  Yeast Protein Translocation Mutant  635 factor and proCPY in lysates of secl8 sec61 cells were performed starting  A 
with spheroplasts prepared as described in the previous section. All subse- 
quent operations were performed at 4"C. Spheroplasts (25 OD~o U) were 
layered over a  10-ml cushion of SPB and 1.9 M sorbitol, and sedimented 
at 5,000 rpm for 5 min in a Sorvall HB-4 rotor (DuPont/Sorvall, Newtown, 
CT). The spheroplast pellet was resuspended in 0.73 ml lysis buffer (0.3 M 
mannitol, 0.1  M KCI, 50 mM Tris, pH 7.5,  1 mM EGTA), transferred to 
a 2.0 ml Potter-Elvejem homogenizer tube, and lysed by three consecutive 
cycles of homogenization (1 min of homogenization followed by 1 min on 
ice) using a motor-driven Potter-Elvejem teflon pestle. After centrifugation 
at 2,000 rpm for 4 rain in a Sorvall HB-4 rotor, the resulting cell-flee extract 
was split into two 0.3-ml aliquots. One sample was adjusted to 0.4% Triton 
X-100, and 40-~1 aliquots (without protease control) from each sample were 
transferred to 0.56 ml of 20% trichioroacetic acid (TCA).  Proteinase K was  B 
added to the remainder of both samples at a final concentration of 0.3 mg/ml, 
and at 0,  1.5, 3,  10, and 20 min, 42-~tl  aliqnots from each sample were 
quenched in 0.56 ml of 20% TCA (processing of the zero time points re- 
quired 15 s). "IV_A  precipitates were collected by centrifugation and washed 
with  -20°C acetone.  Precipitated proteins were solubilized in 50  ~tl of 
Laemmli sample buffer, and samples were diluted and immunoprecipitated 
with anti-a-factor and anti-CPY sera. 
In Vitro Transcription and Translation 
mRNA coding for secreted invertase was prepared by in vitro transcription 
of pGEM2-SUC'2-23 (provided by J. Rothblatt), which contains the entire 
SUC2 gene inserted into pGEM2 downstream of the bacteriophage SP6 pro- 
moter (32). The template was cut with Pvu II, followed by phenol extraction 
and  ethanol  precipitation.  Linear  pGEM2-SUC2-23  (1.2  ~tg) was  tran- 
scribed in a 20-1al reaction using SP6 polymerase as described by Rothblatt 
and Meyer (42). A 1-~tl  aliquot of  the transcription mix was translated (10 Ixl 
reaction) in the BRL nuclease-treated wheat germ in vitro translation sys- 
tem, and the reaction was terminated by adding SDS to 2 % and heating at 
95°C for 4 min. Translation products were immunoprecipitated with anti- 
invertase serum as described above in Radiolabeling  and Immunoprecipita- 
tion. The in vitro translation products shown in Fig. 6, lanes 7 and 9 each 
represent one-sixth of a  10-ttl reaction. 
Hybrid-selected a-factor mRNA was translated in a rabbit reticulocyte 
lysate as described by Bernstein et al. (1). 
Results 
A Selection Scheme for Yeast Translocation Mutants 
Numerous experiments have demonstrated that a signal se- 
quence can direct cytoplasmic proteins to the secretory path- 
way in vivo (7, 47, 49). Based on these data, we reasoned that 
if a signal sequence were attached to a cytoplasmic enzyme 
required for the formation of an essential nutrient, the hybrid 
protein would be directed to the ER. If the substrate of the 
enzyme were limited to the cytoplasm, the cells would not 
grow unless they were supplied with the nutrient. Mutations 
that block hybrid protein import into the ER would allow 
cells to grow on the substrate. 
We chose the HIS4 gene because it encodes a trifunctional 
cytoplasmic  polypeptide  that  can  sustain  amino-terminal 
protein fusion events and retain histidinol dehydrogenase ac- 
tivity associated with the carboxy-terminal domain (24, 40). 
Histidinol dehydrogenase catalyzes the last step in histidine 
biosynthesis, the conversion of histidinol to histidine.  Cells 
that express wild-type HIS4 protein and contain the mutant 
allele  HOLI-1  (this  mutation  increases  the  efficiency  of 
histidinol uptake) are able to convert exogenously supplied 
histidinol to histidine. 
We predicted that if a signal sequence were fused to the 
amino terminus of the HIS4 protein, it would be translocated 
into the lumen of the ER and glycosylated, as shown sche- 
matically in Fig.  1 A. Wild-type cells (bearing the his4-401 
deletion which overlaps the A, B, and C regions of HIS4) ex- 
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Figure I. Predicted topology of a signal peptide-contalning  HIS4 
hybrid protein.  The predicted subcellular location and emzymatic 
properties of a histidinol dehydrogenase fusion protein are shown 
for both (A) wild-type and (B) mutant cells. (CttO) Asparagine- 
linked carbohydrate; (~)  a signal sequence; and (folded black 
trace) the catalytic domain of the fusion protein.  (X) A mutation 
that inactivates either the signal sequence or some cellular compo- 
nent (membrane-bound or cytosolic) required for protein translo- 
cation. 
pressing this plasmid-encoded fusion protein would not con- 
vert histidinol to histidine in that the histidinol dehydrogen- 
ase would be sequestered from the cytoplasm, and charged, 
polar molecules such as histidinol or histidine are unlikely 
to penetrate across the ER membrane. Therefore, these cells 
would not grow on medium containing histidinol in place of 
histidine.  If cells containing this gene fusion were selected 
for growth on histidinol, mutants that mislocalized the fusion 
protein to the cytoplasm would convert the histidinol to histi- 
dine (Fig.  1 B) and grow. 
Potentially this procedure would select for mutations that 
disrupted  signal  sequence  function  or mutations that  dis- 
abled the cellular machinery responsible for targeting secre- 
tory proteins to the ER. These alternative possibilities are in- 
dicated by X marks in Fig.  1 B. Genetic tests (i.e., plasmid 
linkage) may be used to distinguish between these two class- 
es of mutations.  The strains described in this report con- 
tained recessive mutations that caused pleiotropic defects in 
the ER targeting apparatus. 
In order to recover viable, translocation-defective cells, it 
was necessary to strike a balance between the lethal effect of 
secretory mutations and the requirement for sufficient cyto- 
solic histidinol dehydrogenase activity. For this purpose, the 
growth  temperature  (30°C)  represented  a  semipermissive 
condition where the mutant phenotype was only partially ex- 
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tion defects, clones selected for growth on histidinol at 30°C 
were screened on rich medium for "Is growth at 3"/°C, pre- 
sumably owing to an exaggeration of the partial defect ex- 
pressed at 30°C. 
Expression of  HIS4 Hybrid Proteins 
Two conditions were required for the approach to succeed: 
first,  protein products  of HIS4  gene  fusions  must  retain 
histidinol dehydrogenase activity; and second, such a fusion 
protein must be directed to the yeast secretory apparatus in 
vivo, rendering the enzyme unable to supply histidine for 
growth. To test the first requirement, a gene fusion that en- 
codes both a cytoplasmic and a signal peptide-containing hy- 
brid was produced by ligafing the 5' half of the SUC2 coding 
region to a fragment containing the bulk of the HIS4 coding 
region (Fig. 2 A). The SUC2 gene codes for two different 
species of the yeast enzyme invertase (5): a cytoplasmic, un- 
glycosylated form of the enzyme is expressed constitutively, 
and a  secreted, highly glycosylated form is derepressed by 
growth in medium containing low concentrations of glucose. 
The primary structure of these two polypeptides differs only 
in the transitory presence of  a signal peptide at the amino ter- 
minus of  the secreted preenzyme. Yeast cells (h/s4A, HOLI-1) 
transformed with a multicopy plasmid containing the SUC2- 
HIS4  gene  fusion  (pSHE1)  directed  the  synthesis  of two 
different fusion proteins (data not shown).  As expected, a 
nonglycosylated 130-kD species was produced constitutive- 
ly. When transformants were shifted to derepression medium, 
a glycosylated fusion protein was also synthesized. To deter- 
mine whether the cytoplasmic hybrid protein possessed his- 
Figure 2. A SUC2-HIS4 gene fusion confers growth on histidinol. 
(A) The predicted structure of the protein products of the SUC2- 
HIS4 fusion are shown. 4,4, 4B, and 4(7 refer to separate domains 
of the trifunctional HIS4 protein; histidinol dehydrogenase activity 
is encoded by 4C. The signal sequence of secretory invertase is 
shown as  a  small black  rectangle  at  the  NH2 terminus  of the 
derepressed fusion protein. (B) DYFC2-12B cells without plasmid 
(parent), transformed with vector sequences alone (+vector), or 
transformed with a multicopy plasmid containing the SUC2-HIS4 
gene fusion (+SUC2-HIS4) were streaked onto minimal medium 
supplemented with 5 % glucose, leucine, tryptophan,  and 3 mM 
histidinol.  These  growth conditions  should allow production  of 
only the cytoplasmic fusion protein. The plate shown was incubated 
at 30°C for 3.5 d. 
Figure 3. A MFal-SUC2-HIS4  gene fusion does not confer growth 
on histidinol. (,4) The predicted structure of the protein product of 
a MFal-SUC2-HIS4 gene fusion is shown. The signal sequence- 
containing prepro region of a-factor is abbreviated as paE 4A, 4B, 
and 4C are as described in Fig. 2 A. (B) DYFC2-12B cells trans- 
formed with multicopy plasmids containing either the SUC2-HIS4 
(pSHE1) or MFal-SUC2-HIS4 (pctSI-IFS) gene fusion were ana- 
lyzed as described in Fig. 2 B. 
tidinol dehydrogenase  activity, pSHE1 transformants (his4A, 
HOLI-1) were assayed for their ability to grow on minimal 
medium containing histidinol and high concentrations of glu- 
cose. As a control, untransformed cells and cells transformed 
with vector sequences lacking the HIS4 insert were also ana- 
lyzed. The results shown in Fig. 2 B demonstrated that the 
SUC2-HIS4  fusion allowed his4A, HOLI-1 cells to grow on 
histidinol. This capacity was dependent on the HIS4 insert, 
because clones transformed with vector sequences did not 
grow. 
A test of the second condition required elimination of the 
cytoplasmic invertase-histidinol dehydrogenase hybrid pro- 
tein. This requirement was met by replacing the promoter of 
the SUC2 gene with upstream and coding sequences from the 
yeast MFal gene (Fig. 3 A). MFal encodes the precursor 
of the secreted mating pheromone a-factor (27).  Multicopy 
plasmids (paSHF8) bearing this tripartite fusion were intro- 
duced into yeast cells identical to those used in the previous 
experiment. In contrast to the pSHE1  transformants,  cells 
containing  paSHF8  were  not  able  to  grow  on  minimal 
medium plus histidinol (Fig.  3 B). 
Production of the glycosylated hybrid protein encoded by 
paSHF8  was  evaluated with  transformed  cells  that  were 
pulse-labeled with [35S]SO~4- in the presence or absence of 
tunicamycin,  which  inhibits  asparagine-linked  glycosyla- 
tion. Extracts prepared from these cells were treated with in- 
vertase antiserum, which recognizes determinants encoded 
by the SUC2 portion of the fusion. Cells labeled in the ab- 
sence of tunicamycin synthesized two species of fusion pro- 
tein (Fig. 4, lane 1 ). The predominant species migrated with 
a molecular mass of •160  kD, In addition, a minor product 
of 140 kD was detected. When the transformant was labeled 
in the presence of tunicamycin (lane 2), a single polypeptide 
that comigrated with the lower Mr form seen in lane 1 was 
made. The molecular mass of the unglycosylated material in 
lane 2 agreed with that predicted for an unmodified prepro- 
a-factor-invertase-HIS4  hybrid protein.  Both polypeptides 
were plasmid encoded, in that cells containing vector se- 
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fusion plasmid directs the synthe- 
sis ofa glycoprotein. DYFC2-12B 
cells (20D6~o per sample) trans- 
formed  with  pctSHF8  were  la- 
beled  for 20  min at  30°C  with 
[35S]SO~- in the presence  or ab- 
sence of 10 Ixg/ml  tunicamycin af- 
ter a 15-rain pretreatment with or 
without tunicamycin,  respective- 
ly.  Whole-spheroplast  extracts 
were  treated  with  anti-invertase 
serum and the immunoprecipitates 
were fractionated on a 7.5 % SDS- 
polyacrylamide gel. Lanes 1 and 
2 are individual tracks from a sin- 
gle polyacrylamide gel. 
quences did not express any high Mr cross-reactive material 
(data not shown).  Also, both products were under mating- 
type regulation, because neither MATa haploids nor MATa/ 
MATa diploids transformed with pctSHF8 expressed any hy- 
brid  protein  as  expected  for a  gene under  the  control  of 
MATs (data not shown).  The nature of the  140-kD species 
seen in lane 1 was not examined further.  In any event, this 
plasmid did not complement the chromosomal his4 deletion. 
These data suggested that the pctSHF8 transformants were 
unable to grow on histidinol because the majority of hybrid 
protein was localized to the secretory pathway. 
Isolation of Temperature-sensitive 
Histidinol Prototrophs 
Inasmuch as  the  primary assumptions were confirmed by 
these experiments, the histidinol  selection scheme was ap- 
plied to yeast cells (DYFC2-12B; see Table I) containing the 
MFal-SUC2-HIS4 fusion plasmid. Transformants were mu- 
tagenized with ethyl methanesulfonate,  allowed to  recover 
overnight in minimal medium (-uracil) at 30°C,  and plated 
on minimal medium (-uracil) with histidinol  substituted for 
histidine. After incubation for 5-7 d at 30°C, plates were ex- 
amined  for the  presence of histidinol  prototrophs (histidi- 
nol÷).  The  frequency of mutations that allowed growth on 
histidinol  was  ~2.5  x  10  -5  (Table II,  round  I).  440  his- 
tidinol  prototrophs  were  then  screened  for  Ts  growth  on 
rich  medium at  37°C.  Five clones  exhibited  both  Ts  and 
histidinol ÷ phenotypes.  Derivatives of all five isolates that 
had been cured of the plasmid were not able to grow on his- 
tidinol,  confirming that the histidinol  ÷ phenotype was de- 
pendent on the plasmid. These cells also exhibited Ts growth 
on rich medium, demonstrating that thermosensitivity was 
caused  by  a  chromosomal mutation.  Retransformation  of 
these clones with unmutagenized p~tSHF8 restored growth 
on  histidinol  medium,  demonstrating  that  this  phenotype 
was  also  due  to  a  chromosomal mutation,  as  opposed to 
plasmid-linked defects such as signal sequence mutations. 
Secretion defects were tested directly by assaying for the 
accumulation of secretory precursors in plasmid-cured de- 
rivatives from four of the original isolates.  Whole-cell ex- 
tracts were fractionated by SDS-PAGE and immunoblotted 
with antiserum that reacts with prepro-ct-factor. Three of the 
mutants accumulated a precursor form of a-factor that was 
not seen in wild-type cells. 
A genetic relationship between the thermosensitive growth 
and  a-factor  accumulation  phenotypes  was  evaluated  by 
backcrossing two mutants to wild-type strains.  Tetrads de- 
rived from these crosses exhibited low spore viability, and 
we discovered that this was because the original isolates were 
diploid.  The unmutagenized parent strain was also diploid, 
possibly as a result of the transformation procedure. Haploid 
mutants were obtained from two of the isolates by mating 
with MATa/MATa diploids to form tetraploids,  followed by 
two consecutive rounds of meiosis and tetrad analysis. Back- 
crosses of these haploid mutants to wild-type strains revealed 
that both Ts defects segregated as single mutations (two Ts 
and two wild-type spores in  19/19 tetrads analyzed in each 
cross). Thermosensitivity was inseparable from the prepro- 
a-factor accumulation property in that  10 out of 19 MATa 
spore clones were Ts and each accumulated prepro-ct-factor. 
All  nine wild-type progeny, however,  failed to accumulate 
prepro-et-factor. 
Heterozygous diploids, derived by mating both Ts mutants 
to wild-type strains, grew at 37°C, demonstrating that the Ts 
mutations were recessive. Precursor forms of carboxypepti- 
dase Y  and invertase detected in haploid mutant cells were 
absent in the heterozygotes, indicating that the accumulation 
phenotypes were recessive also. Because the parental strain 
was diploid, these recessive mutations may have been recov- 
ered by gene conversion or mitotic recombination events that 
occurred during or shortly after mutagenesis. Complementa- 
tion analysis revealed that all five Ts mutations were allelic, 
Table II.  Histidinol Selection  Scheme Enriches for Temperature-sensitive  Translocation  Mutants 
Round I*  Round II~ 
Colonies analyzed/  Fraction§  Colonies analyzed/  Fraction§ 
Stage of mutant isolation  total colonies  of total  total colonies  of total 
Cells plated on histidinol medium 
Histidinol prototrophs (histidinol  +) 
Temperature-sensitive for growth 
Accumulation of a-factor precursorl 
2  ×  107  -  2.4  ×  107  - 
492  2.5  ×  10  -~  1,600  6.7  ×  10  -~ 
511/440  2.8  ×  10  -7  58/600  6.4  ×  10  -6 
3/4  2.1  ×  10  -7  7/40  1.1  ×  10  -6 
* DYFC2-12B diploid cells were used for mutant isolation. 
FC2-12B haploid cells were used for mutant isolation. 
§ This value represents the number of colonies exhibiting a  given phenotype (or the number expected to exhibit that phenotype, if all colonies were analyzed) 
divided by the number of cells plated on histidinol. 
II All of these  isolates are allelic. 
¶ Immunoblots of whole cell lysates were probed with a-factor antiserum as described in Materials and Methods. 
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nonpermissive and semipermissive temperatures in see61 strains. 
RDM  15-5B (see61) and RDM  15-9B (SEC  +) cells were labeled 
with [35S]SO~- at 30°C for 30 min (lanes 1 and 2) or at 37°C for 
30  min  after  a  60-min  incubation  at  37°C (lanes  3  and  4). 
Spheroplast pellet lysates were prepared and incubated with anti-a- 
factor serum. Immunoprecipitates were evaluated by SDS-PAGE  on 
a 12.5% polyacrylamide gel. Each lane contains the material de- 
rived from 0.5 OD60o U of cells. Glycosylated prepro-a-factor  in 
transit  through  the  secretory  pathway is designated gpaF; pctF 
refers to prepro<t-factor. /VT (lane 5) is the in vitro translation 
product of  prepro-ct-factor  mRNA. Lanes 1-5 were all derived from 
a single polyacrylamide gel. 
although it was not certain that the mutations were of inde- 
pendent origin.  The gene defined by these mutations  was 
designated sec61. 
To assess  whether the proportion of Ts,  histidinol  ÷ mu- 
tants among a population of mutagenized haploid cells might 
be substantially greater, the procedure was repeated using 
haploid  FC2-12B  cells transformed with paSHF8.  As  ex- 
pected,  the  frequency of "seal' mutants  obtained from the 
histidinol selection was about fivefold greater when haploid 
cells were used (Table II, round II). All seven candidates ob- 
tained from round II complemented see61. At least one addi- 
tional  complementation group was  been identified among 
these isolates. The phenotype of strains bearing a mutant al- 
lele of this gene, see62,  is being investigated. 
see61 Cells Accumulate Unprocessed 
t~-Factor Precursor 
More information on the effect of the see61 mutation was ob- 
tained by assessing the fate of prepro-a-factor expressed at 
the semipermissive and nonpermissive temperatures. Wild- 
type cells labeled for 30 min at either 30 or 37°C contained 
very little a-factor cross-reactive material (Fig.  5,  lanes 2 
and 4) because of the rapid rate of a-factor secretion (22). 
At  30°C,  a  trace  amount  of core-glycosylated prepro-ct- 
factor (gpaF) in transit through the early stages of  the secre- 
tory pathway was detected (lane 2). 
When see61 ceils were labeled for 30 min at 30°C or 30 
min at 37°C after a  60-min preshift to the nonpermissive 
temperature, a distinct species of a-factor precursor (paF) 
was accumulated (Fig. 5, lanes I and 3). This form of a-fac- 
tor was not detected in wild-type cells at either temperature. 
The expression of a secretory defect at both 30 and 3"/°C was 
predicted by the selection scheme, which required that cells 
be partially defective at the growth temperature. Mutant cells 
also accumulated substantial amounts of a-factor precursor 
at 24°C. Additionally, see61 strains grew slower than wild- 
type yeast at several temperatures, suggesting that there was 
no completely permissive temperature for see61 function. 
Though a  preshift to 37°C  exaggerated the mutant pheno- 
type, it did not completely inhibit a-factor secretion, in that 
even after a 60-min preshift to the nonpermissive tempera- 
ture, newly synthesized biologically active pheromone was 
detected in the growth medium (not shown). The precursor 
that accumulated at the see61 block comigrated with the in 
vitro translation product of hybrid selected MFal mRNA 
electrophoresed on the same SDS-polyacrylamide gel (lane 
5). This result demonstrated that see61 cells accumulated a 
form of a-factor that was not detectably modified either by 
glycosylation or proteolytic processing (22).  One possible 
interpretation was that the see61 mutation blocked an early 
event in protein translocation, prior to addition of core oligo- 
saccharides in the lumen of the ER. 
Multiple Unprocessed Secretory Proteins Accumulate 
in sec61 Cells 
a-Factor shares early stages of the secretory pathway with 
other cell surface and vacuolar proteins (22), hence see61 
should interrupt the processing and localization of these pro- 
teins as well. This point was tested for the cell wall enzyme 
invertase and  the vacuolar enzyme CPY  by radiolabeling 
wild-type and  mutant  cells  at  30  and  37°C,  and  treating 
spheroplast lysates with antisera reactive with each protein. 
Evaluation of CPY precursor forms was complicated by 
the coincident electrophoretic mobilities of the unglycosyl- 
ated  precursor and  the  glycosylated mature  species  (50). 
This problem was circumvented by introduction of the pep4-3 
mutation  which blocks  proenzyme cleavage (16). In  SEC 
pep4-3  strains radiolabeled at 30 or 37°C (Fig. 6 A, lanes 2 
and 4),  two forms of proCPY were seen:  plCPY,  a  core 
glycosylated 67-kD precursor in transit through the ER, and 
a mature (M) 69-kD species that is found in the Golgi body 
and vacuole (50). 
A  novel form of proCPY  was  seen when see61 pep4-3 
strains were radiolabeled at 30 or 37°C after a 2-h incubation 
at the nonpermissive temperature. The new 58-kD species 
migrated as predicted for the primary translation product of 
the gene encoding CPY (53). At 30°C the see61 defect was 
incomplete, in that both pl  and mature forms of proCPY 
were also detected. After a  120-rain  preshift to 37°C, how- 
ever, all of  the newly synthesized proCPY accumulated at the 
see61 block.  With  shorter 37°C  preincubations  (30 or 60 
rain), a fraction of the proCPY synthesized at 37°C escaped 
the see61 block and appeared as the pl  and mature forms 
(data not shown). These data suggested that the see61 muta- 
tion was leaky, and required long temperature shifts to be 
fully expressed. 
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of invertase and CPY accumulate 
in sec61 cells.  (A) The same ex- 
tracts that were used for the ex- 
periment described in Fig. 5 were 
treated  with  anti-CPY  serum. 
Immunoprecipitates  were  frac- 
tionated  on a  single 7.5% poly- 
acrylamide  gel.  Lanes  1 and 2, 
cells were labeled at 30°C for 30 
min; lanes 3 and 4, cells were la- 
beled at 37°C for 30 min after a 
120-min preincubation  at  37°C. 
Lanes  1-4 contain  the  material 
derived  from  0.20Dt00  U  of 
cells.  P1,  M,  and  *  refer  to 
glycosylated  proCPY  in  transit 
through the ER, mature proCPY 
in the Golgi body or vacuole, and 
proCPY accumulated at the sec61 
block,  respectively.  (B)  RDM 
15-5B (sec61) and  RDM  15-9B 
(SEC  +)  cells  were  labeled  with 
[35S]SO~4- for  30  min  at  30°C 
(lanes 5 and 6) or for 30 min at 
37°C after a  120-min incubation 
at 37°C (lanes 8 and 10). Before 
each labeling,  cultures  were de- 
repressed  for  invertase  produc- 
tion  in  0.1% glucose  minimal 
medium at 30°C for 30 min (lanes 
5 and 6) or at 37°C for 30 min (lanes 8 and 10). Whole-spheroplast lysates were prepared and treated with anti-invertase serum. Immune 
complexes were harvested and analyzed by SDS-PAGE on a 7.5% polyacrylamide gel. Lanes 5, 6, 8, and 10 represent the total invertase 
derived from 0.50D~o0 U of cells./VT (lanes 7 and 9) is the in vitro translation product of secreted invertase mRNA. ER, cyto, and * 
refer to core glycosylated invertase in transit through the ER, cytoplasmic (unglycosylated) invertase, and secretory preinvertase accumulated 
by the sec61 mutation,  respectively. 
Additional  information  concerning  the  position  of the 
sectl  block was revealed by analysis of radiolabeled inver- 
tase. Wild-type cells produced three discrete types of inver- 
tase at 30 or 37°C  (Fig.  6 B, lanes 6 and 10).  Core-glyco- 
sylated intermediates in transit through the ER and highly 
glycosylated  cell  wall  molecules  were  synthesized  in  re- 
sponse to glucose deprivation. A  nonglycosylated cytoplas- 
mic enzyme was made constitutively (9). Besides these spe- 
cies,  sectl  mutant  cells  labeled  at  30°C  or  after  a  2-h 
incubation at 37°C accumulated an additional form (lanes 5 
and 8) that comigrated with the in vitro translation product 
of secretory invertase mRNA (Fig. 6 B, lanes 7and 9). The 
difference in Mr between the secreted and cytoplasmic pri- 
mary translation products is due to the presence of a signal 
peptide  at  the amino terminus of the  secretory preprotein 
(41). Comigration of sectl-specific invertase with the signal 
sequence-containing  in  vitro translation  product  indicated 
that the sectl  defect was imposed prior to  signal peptide 
cleavage. 
Based on the SDS gel mobility of precursors accumulated 
in sectl cells, the block appeared to precede the addition of 
asparagine-linked core  oligosaccharides,  which  are  trans- 
ferred to protein in the lumen of the ER. This prediction was 
tested directly by treating  extracts  from [35S]SO~F-labeled 
sectl cells with the mannose-binding lectin Con A immobi- 
lized on Sepharose beads. Beads were recovered by centrifu- 
gation,  pellet and  supernatant  fractions were treated  with 
SDS, and the distribution of accumulated precursors was as- 
sessed by immune precipitation with a-factor and CPY an- 
tisera. The data in Fig. 7 A, lane I  show the total complement 
of a-factor present in the sectl extract derived from the same 
sample depicted in Fig.  5,  lane  1.  When mixed with Con 
A-Sepharose and separated into pellet (lane 3) and superna- 
rant (lane 2) fractions, glycosylated prepro-a-factor in transit 
through the ER was quantitatively recovered in the bound 
fraction, whereas prepro-a-factor accumulated by the sec61 
mutation remains in the supernatant. The results obtained for 
proCPY were similar to those for a-factor. The data in Fig. 
7  B,  lane 4  shows the proCPY present in the total extract 
(same sample as Fig.  6,  lane 1).  Mature and plCPY were 
bound to the Con A-Sepharose (lane 5), although some ma- 
terial was lost in sample preparation. In contrast, the sec61- 
specific proCPY (*) was quantitatively recovered in the un- 
bound fraction (lane 6).  Preinvertase accumulated in sectl 
mutants behaved identically to proCPY and prepro-a-factor 
(data not shown).  In all cases, the association was specific 
for mannose,  as binding was prevented by the competitor, 
a-methylmannoside (data not shown). 
sec61-Accumulated Preproteins Are Exposed to 
the Cytoplasm 
The histidinol selection scheme demanded that a prepro-a- 
factor-invertase-HIS4 chimeric protein accumulate in a loca- 
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block do not bind to Con A. (A) The [35S]SO~4-  labeled extract (0.5 
ODmo per lane) used to generate the sample shown in Fig. 5, lane 
1 was directly immunoprecipitated with anti-a-factor serum (lane 
1),  or was treated with  Con A-Sepharose 4B  and separated by 
sedimentation into bound (lane 3) and free (lane 2) fractions prior 
to immunoprecipitation. T, S, and P are abbreviations for the total, 
supernatant, and pellet fractions. The position of the glycosylated 
a-factor precursor is indicated by gpaF; sec61-specific  prepro-a- 
factor is indicated by * (B) Same as in A, except the sample used 
(0.30D600 per lane) is identical to Fig. 6, lane 1.  Lane 4, total 
CPY antigen; lane 5, bound (pelle0 proCPY species; lane 6, free 
(supernatant) proCPY material. P1, m, and * are as described in 
Fig. 6 A. 
tion accessible to histidinol. The most likely location of this 
fusion protein,  and of preproteins whose localization was 
perturbed by the sec61 mutation, was in the cytoplasm or on 
the cytoplasmic face of the ER. The lack of detectable modi- 
fications on preproteins accumulated by the sec61  cells was 
consistent with this prediction. To test directly whether these 
precursors were exposed to the cytoplasmic compartment, 
extracts of [35S]SO~--labeled  sec61  cells  were exposed to 
protease in the absence and presence of detergent. Proteoly- 
sis was terminated by the addition of TCA, and the quenched 
reactions were evaluated by immune precipitation with anti- 
a-factor and anti-CPY sera,  followed by SDS-PAGE. 
Extracts were prepared from a strain in which the disposi- 
tion of precursor polypeptides and the integrity of ER vesi- 
cles could be evaluated simultaneously. For this purpose, a 
strain bearing mutant copies of  the secl8 and sec61 genes was 
constructed. The secl8 mutation, which is nonpermissive at 
30°C,  causes  core-glycosylated secretory proteins  to  ac- 
cumulate within the lumen of the endoplasmic reticulum (9, 
36). When secl8 sec61 mutants grown at 24°C were shifted 
to 30°C, a fraction of the newly synthesized prepro-a-factor 
was accumulated at the sec61 stage. The prepro-a-factor that 
escaped the sec61  block became core-glycosylated and ar- 
rested by the secl8  mutation.  This glycosylated prepro-a- 
factor served as a reference for the lumen of the endoplasmic 
reticulum. The results in Fig. 8 A document the sensitivity 
of glycosylated prepro-a-factor and prepro-a-factor to pro- 
teinase K.  When no protease was added (lanes 1  and  7), 
glycosylated and  unglycosylated forms  of prepro-a-factor 
were seen. Upon exposure to protease for increasing lengths 
of time in the absence of detergent (lanes 2-6), the amount 
of sec61  accumulated prepro-a-factor diminished gradually 
while the lowest mobility secl8 form (glycosylated prepro-a- 
factor) remained resistant to digestion. After a 20-min incu- 
bation with proteinase K, 90%  of the prepro-a-factor was 
degraded, while 85 % of the glycosylated form was resistant 
to proteolysis. The residual amount (10%) of prepro-a-factor 
that resisted protease action was similar to the fraction of 
NADPH cytochrome c reductase activity that was latent in 
this extract (see below). In the presence of detergent (lanes 
8-12), all species of prepro-a-factor were degraded rapidly; 
the digestion was essentially complete after 3-rain (lane 10). 
As  a  control to  estimate the proportion of lysed mem- 
branes in the extract, a  mock-digested aliquot was centri- 
fuged to obtain pellet and supernatant fractions, u-Factor im- 
munoprecipitates of these fractions are displayed in lanes 13 
and 14. The extent of  protection ofsecl8 prepro-a-factor was 
proportional to the amount of  material that sedimented (com- 
pare lane 6 with lane 13). Prepro-a-faetor accumulated at the 
sec61 block, however, was almost completely protease sensi- 
tive in  the absence of detergent (lane  6),  even though it 
sedimented quantitatively (lane 13). Though clearly accessi- 
ble to exogenous protease, the rate of prepro-a-factor diges- 
tion was accelerated two- to threefold by detergent. This may 
reflect increased exposure of this material to protease in the 
presence of  detergent, implying that prepro-a-factor retained 
at  the sec61  block was  associated with  some membrane- 
bound component, or directly with the phospholipid bilayer. 
Protease sensitivity of accumulated prepro-a-factor was 
also examined in a homogenate prepared from a sec61 SECI8 
strain. Although these samples did not contain the glycosyl- 
ated control, the unglycosylated precursor was degraded at 
a rate similar to that seen in Fig.  8 A.  Hence, proliferated 
ER membrane produced by the secl8 block (36) did not alter 
the behavior of the sec61  species. 
Fig. 8 B documents the protease sensitivity of  the secl8 and 
sec61  forms of proCPY present in the same extract. In the 
absence of detergent, proCPY that accumulated at the secl8 
block was refractory to proteolysis over a 20-min incubation, 
while  proCPY  held  at  the  sec61  block  was  completely 
digested within 1.5 min (lanes 2-6). In the presence of deter- 
gent, all species of proCPY were susceptible to proteolysis, 
though the glycosylated proCPY was only partially digested 
(lanes  8-12).  The  results  in  lane  13 demonstrate that the 
majority of  proCPY present in this extract was sedimentable. 
To ensure that the surface of the ER membrane was acces- 
sible to proteinase K, assays were performed to determine 
the latency of  the cytoplasmically exposed ER membrane en- 
zyme, NADPH cytochrome c reductase (25), to its substrate 
cytochrome c. Assays performed with the same extract used 
in these experiments indicated that only 10% of  the reductase 
activity was latent. 
Prepro-a-Factor Accumulated in sec61 
Cells Is Particulate 
The particulate nature  of prepro-a-factor in  extracts pre- 
pared from secl8 sec61  mutant cells (Fig. 8 A, lane 13) was 
examined in more detail. Spheroplast lysates were subjected 
to differential centrifugation and subcellular fractions were 
assayed for NADPH cytochrome c reductase and glyceralde- 
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and proCPY in secl8 sec61 cell extracts. 
RDM  15-3A cells were labeled and ly- 
sates were prepared as described in Ma- 
terials and Methods. Aliquots of the ly- 
sate were mock digested (lanes I and 7) 
or  were  treated  with  300  txg/ml pro- 
teinase K in the absence (lanes 2-6) or 
presence  (lanes  8-12) of 0.4% Triton 
X-100 for 0-20 min on ice. A separate 
aliquot  was fractionated  by centrifuga- 
tion into pellet (lane 13) and supernatant 
(lane  14)  fractions.  (A)  Samples  were 
quenched  with  TCA, immunoprecipi- 
tated  with  anti-a-factor  serum,  and 
evaluated  by  SDS-PAGE on  a  12.5% 
polyacrylamide gel. Each lane contains 
the amount  of prepro-a-factor precipi- 
tated from 1.20D~ U of  cells, u-Factor 
precursors accumulated by the secl8 and 
sec61  mutations  are  designated  gpaF 
and paF, respectively. (B) Aliquots from 
the  proteolysis  reactions  were  treated 
with anti-CPY serum and immunopre- 
cipitates  were  analyzed  by SDS-PAGE 
on  a  7.5% polyacrylamide  gel.  Each 
lane contains total CPY antigen derived 
from 0.40D~00 U of cells. ProCPY ac- 
cumulated at the secl8 and sec61 stages 
is designated ER and *  respectively. 
hyde-3-phosphate  dehydrogenase,  a  cytoplasmic  enzyme. 
Aliquots of each fraction were also evaluated by SDS-PAGE 
and immunoblotting with a-factor antiserum to monitor the 
fractionation properties of prepro-a-factor accumulated  at 
the secl8 and sec61 blocks. As in the previous experiment, 
precursors accumulated by the secl8 mutation served as a 
marker for the lumen of the ER.  The enzyme assay results 
are presented in Table III. As expected, the cytosolic marker 
was quantitatively recovered in the high-speed supernatant 
(HSS).  NADPH  cytochrome c  reductase  sedimented  pre- 
dominantly in the high speed pellet fraction;  ~30%  of the 
reductase activity sedimented in the low speed pellet frac- 
tion. An anti-a-factor immunoblot is shown in Fig.  9.  The 
three lower mobility forms of a-factor precursor seen in the 
extract (lane 1 ) corresponded to different glycosylated spe- 
cies (22) that were accumulated in secl8 mutants (compare 
the secl8 extract in lane 7 with the wild-type extract in lane 
6). The highest mobility band in lanes 1-5 corresponded to 
prepro-a-factor accumulated at the sec61 block, and comi- 
grated with the in vitro translation product. The unglycosyl- 
ated prepro-ct-factor sedimented exclusively with the partic- 
ulate fractions, whereas lumenal glycosylated prepro-a-factor 
was distributed between the high speed supernatant and pel- 
let  fractions,  presumably due  to  some rupture  of the  ER 
membrane  during  cell  lysis.  The  sedimentation  of sec61- 
accumulated prepro-ct-factor was not influenced by the secl8 
mutation,  in that extracts of sec61  mutants yielded similar 
results. In addition, proCPY accumulated in this mutant was 
recovered in the sedimentable fraction of a lysate (data not 
shown). 
Discussion 
A  genetic selection has been devised to identify genes re- 
quired for secretory protein translocation into the ER. This 
selection procedure demands that a  signal peptide-contain- 
ing cytoplasmic enzyme, whose location has been diverted 
to  the  secretory pathway,  be  retained  in  contact  with  the 
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Enzyme  Cellular location  Subcellular fraction  % Activity  Specific  activity 
Glyceraldehyde-3-P dehydrogenase  Cytoplasm  Extract  100  2.55 
HSS  112  5.32 
HSP  0.2  0.013 
NADPH  cytochrome c  reductase  ER membrane  Extract  100  0.178 
HSS  5.6  0.026 
HSP  80.5  0.307 
Subcellular fractions from the experiment depicted in Fig. 9 were assayed for their content of glyceraldehyde-3-P dehydrogenase and NADPH cytochrome c reduc- 
tase activities as described in Materials and Methods. HSS and HSP, high-speed supernatant and pellet fractions, respectively. Each value presented is the average 
of the initial  rates of activity measured in three independent trials.  Specific  activity is expressed as AAss0  ,m per minute per milligram of protein for NADPH 
cytochrome c reductase and AA~0 ~  per minute per milligram of protein for glyceraldehyde-3-P dehydrogenase. 
cytosol because of a defect in the cellular translocation ma- 
chinery. Mutations in two genes have been isolated that cause 
temperature sensitive growth and accumulation of prepro-ct- 
factor. Because the selection demands that mutant cells ex- 
press a  partial defect at a temperature that permits growth 
(30°C),  accumulation of a-factor precursor is seen at 30°C 
and is enhanced at the restrictive temperature (37°C). These 
phenotypes are the result of single lesions, inasmuch as tem- 
perature sensitivity and secretory protein accumulation co- 
segregate when mutants are backcrossed to wild type strains. 
sec61,  the mutant described in this report, also accumu- 
lates preinvertase and procarboxypeptidase (proCPY). Pre- 
sumably other secretory proteins that are essential for yeast 
cell growth are also blocked in this mutant. We have not yet 
Figure 9. Fractionation  of prepro-~t-factor species accumulated in 
secl8 sec61 cells. Extracts of RDM 15-3A cells (secl8 sec61) were 
prepared and fractionated as described  in Materials and Methods. 
Protein (30 Ixg)  from each fraction was electrophoresed on a 12.5  % 
polyacrylamide  gel and immunoblotted with anti-a-factor serum. 
Lane 1, whole extract; lane 2,660 - g pellet;  lane 3, 660 - g su- 
pernatant;  lane 4,  100,000 - g pellet;  lane 5,  100,000 - g superna- 
tant. Ex, LSP, LSS, lISP, and HSS refer to extract, low-speed and 
high-speed pellet,  and supernatant fractions,  respectively. ER and 
* indicate forms of prepro-a-factor arrested by the secl8 and sec61 
mutations.  Unfractionated  extracts  of RDM  15-9B (SEC  +)  and 
RDM  15-10D (secl8)  strains  were  prepared,  subjected  to  SDS- 
PAGE, and immunoblotted as described  above. Lane 6, whole ex- 
tract from RDM 15-9B; lane 7, whole extract from RDM 15-10D. 
examined membrane protein precursors, many of which do 
not contain classical amino-terminal signal  sequences  (18, 
34, 52). These properties could alter the assembly pathway 
of a protein. This possibility may be tested by evaluating the 
integration of membrane proteins into the ER membrane of 
sec61  mutant cells. 
Preproteins  accumulated  at  the  sec61  block  are  not 
glycosylated, and their signal sequences have not been re- 
moved. These properties are expected for a molecule that has 
not yet engaged, or has only partly penetrated the ER mem- 
brane bilayer. Precursor forms of two secretory proteins are 
sedimentable but susceptible to exogenous proteolytic attack 
though the ER membrane remains largely intact. 
a-Factor precursor made in an in vitro yeast protein syn- 
thesis reaction is soluble and becomes sedimentable only af- 
ter  translocation  into  ER  vesicles  (15).  In  contrast,  both 
~t-factor  and  CPY  precursors  sediment  along with  mem- 
branes in extracts of sec61 cells. This property could repre- 
sent  an  intermediate  stage in  the  translocation process  in 
which  precursors  become firmly  associated  with  the  ER 
membrane (6), or could simply result from aggregation or 
nonspecific binding of precursors to membranes within mu- 
tant  cells.  Synthetic  signal  peptides  and  intact  secretory 
precursor proteins have the capacity to insert into and at least 
partly through lipid monolayers and vesicle bilayers in vitro 
(3, 38). The physical basis of the sedimentability of precur- 
sor proteins may be established by fractionation of mem- 
branes from sec61  mutant ceils. 
Comparable blocks in secretion have been explored with 
Escherichia coli.  Secretory precursors accumulate in ther- 
mosensitive mutants such as SecA, SecB, and SecY (21, 26, 
39), or in wild-type cells that express high levels of maltose 
binding  protein-13-galactosidase hybrid proteins  (20).  Cell 
fractionation  experiments have  shown  that  the  precursors 
distribute between the periplasmic, membrane, and cytosolic 
fractions in proportions that are influenced by the monova- 
lent ion concentration (20).  In these conditions the prepro- 
teins may associate with the cytoplasmic membrane nonspe- 
cifically via the hydrophobic signal peptide. 
A specific effect on the initial step in the secretory pathway, 
as opposed to a more general disruption of protein transport, 
is indicated by the pattern of precursors that appear in sec61 
ceils at the semirestrictive temperature, 30°C. Accumulation 
of core- or highly-glycosylated forms of a-factor, invertase, 
or CPY is expected in mutants with impaired intercompart- 
mental protein transport from the ER or the Golgi body (9, 
22,  50).  In contrast, sec61  mutants show no such accumu- 
lation. 
Deshaies and Schekman Yeast Protein  Translocation  Mutant  643 sec61 Mutant cells require 37°C preincubation periods of 
at least 2 h before the secretion block becomes complete. 
This long lag time suggests that the sec61 mutant protein is 
thermolabile for synthesis or association with an oligomeric 
complex, rather than thermosensitive for function. Alterna- 
tively, the mutant protein may be thermolabile in performing 
a  modification that is required for the activity of another 
component of  the translocation machinery. In either case, the 
defect would become more pronounced only as active spe- 
cies are replaced by inactive forms. 
Two other yeast mutants, sec53 and sec59, are defective in 
an early stage of secretory protein biogenesis (12). Pheno- 
typic characterization demonstrated that these Ts mutants 
accumulate underglycosylated, inactive precursors  at  the 
nonpermissive temperature (12). Initial protease protection 
experiments suggested that preinvertase is abortively translo- 
cated, remaining tightly associated with the ER membrane 
but accessible to trypsin in a homogenate (11). More refined 
methods for performing proteolysis experiments, however, 
have now shown that the partially glycosylated prepro-ct- 
factor, invertase, and proCPY that accumulate in these mu- 
tants are completely protected against trypsin and protease 
K attack in the absence of, but not in the presence of deter- 
gent (10a). Because invertase accumulated in sec53 and sec59 
mutants  has  had  its  signal  peptide  removed,  is  partially 
glycosylated and apparently resides within the lumen of the 
ER (10a), the sec61 defect must precede the block imposed 
by sec53 or sec59. In addition, the sec61 mutation comple- 
ments both sec53 and sec59 mutations, indicating that sec61 
defines a new function in the secretory pathway. 
By characterizing the phenotypes of  additional import mu- 
tants we may be able to reconstruct the events that occur dur- 
ing protein translocation in vivo (35). An examination of the 
properties of these mutants in the yeast in vitro protein trans- 
location assay should further our understanding of the mo- 
lecular mechanism of  protein translocation into the yeast en- 
doplasmic reticulum. 
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